United States · FDA National Drug Code directory
lamivudine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68999-706_476c3997-b596-17d2-e063-6394a90a6ca1
- Product NDC
- 68999-706
- Form
- SOLUTION
- Composition / generic term
- lamivudine oral
- Labeler
- Chartwell Govermental & Specialty RX, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141031
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMIVUDINE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TRAY in 1 BOX (68999-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30) · 68999-706-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →